glp-1 receptor agonist side effects Gastrointestinal effect and adverse of Is GLP-1 the Same as

JCI Insight 6 (23), e93382

Eur Heart J Cardiovasc Pharmacother 10(1):79

The trial in individuals without T2D reveals a mean weight loss of 6.2% with 120 mg versus no change in the placebo group

Back rskov, C, Holst JJ (April 1987) 'Radio-immunoassays for glucagon-like peptides 1 and 2 (GLP-1 and GLP-2)', Scandinavian Journal of Clinical and Laboratory Investigation , 47/2, 165-74.Back rskov, C, Holst, JJ, Seier Poulsen, S, Kirkegaard, P (Nov 1987) 'Pancreatic and intestinal processing of proglucagon in man', Diabetologia, 30, 874-81

In agreement, the KaplanMeier curves from two prior intention-to-treat analyses also showed less benefit of GLP1 receptor agonists versus SGLT2 inhibitors after several years of follow-up [16, 25]